Kurs & Likviditet
Kalender
2025-02-23 | Bokslutskommuniké 2024 |
2024-11-08 | Kvartalsrapport 2024-Q3 |
2024-08-16 | Kvartalsrapport 2024-Q2 |
2024-05-23 | X-dag bonusutdelning RAY B 1.3 |
2024-05-23 | X-dag ordinarie utdelning RAY B 0.70 SEK |
2024-05-22 | Årsstämma |
2024-05-17 | Kvartalsrapport 2024-Q1 |
2024-02-23 | Bokslutskommuniké 2023 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-26 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2023-05-25 | Årsstämma |
2023-05-17 | Kvartalsrapport 2023-Q1 |
2023-02-28 | Bokslutskommuniké 2022 |
2022-11-29 | Kvartalsrapport 2022-Q3 |
2022-08-29 | Kvartalsrapport 2022-Q2 |
2022-05-27 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2022-05-25 | Årsstämma |
2022-05-18 | Kvartalsrapport 2022-Q1 |
2022-02-23 | Bokslutskommuniké 2021 |
2021-11-18 | Kvartalsrapport 2021-Q3 |
2021-08-25 | Kvartalsrapport 2021-Q2 |
2021-05-27 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2021-05-26 | Årsstämma |
2021-05-05 | Kvartalsrapport 2021-Q1 |
2021-02-23 | Bokslutskommuniké 2020 |
2020-11-18 | Kvartalsrapport 2020-Q3 |
2020-08-26 | Kvartalsrapport 2020-Q2 |
2020-07-01 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2020-06-30 | Årsstämma |
2020-05-05 | Kvartalsrapport 2020-Q1 |
2020-02-14 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-20 | Kvartalsrapport 2019-Q2 |
2019-05-22 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2019-05-21 | Årsstämma |
2019-05-09 | Kvartalsrapport 2019-Q1 |
2019-02-20 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-23 | Kvartalsrapport 2018-Q2 |
2018-05-31 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2018-05-29 | Årsstämma |
2018-05-09 | Kvartalsrapport 2018-Q1 |
2018-02-15 | Bokslutskommuniké 2017 |
2017-11-22 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-24 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2017-05-23 | Årsstämma |
2017-05-19 | Kvartalsrapport 2017-Q1 |
2017-02-17 | Bokslutskommuniké 2016 |
2016-11-18 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-18 | X-dag ordinarie utdelning RAY B 0.25 SEK |
2016-05-17 | Årsstämma |
2016-05-12 | Kvartalsrapport 2016-Q1 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-11-25 | Kvartalsrapport 2015-Q3 |
2015-08-28 | Kvartalsrapport 2015-Q2 |
2015-05-29 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2015-05-28 | Årsstämma |
2015-05-08 | Kvartalsrapport 2015-Q1 |
2015-02-12 | Bokslutskommuniké 2014 |
2014-11-27 | Kvartalsrapport 2014-Q3 |
2014-08-27 | Kvartalsrapport 2014-Q2 |
2014-05-28 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2014-05-27 | Årsstämma |
2014-05-16 | Kvartalsrapport 2014-Q1 |
2014-02-13 | Bokslutskommuniké 2013 |
2013-11-27 | Kvartalsrapport 2013-Q3 |
2013-08-28 | Kvartalsrapport 2013-Q2 |
2013-05-23 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2013-05-22 | Årsstämma |
2013-05-16 | Kvartalsrapport 2013-Q1 |
2013-02-14 | Bokslutskommuniké 2012 |
2012-11-16 | Kvartalsrapport 2012-Q3 |
2012-08-28 | Kvartalsrapport 2012-Q2 |
2012-05-31 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2012-05-30 | Årsstämma |
2012-05-23 | Kvartalsrapport 2012-Q1 |
2012-02-16 | Bokslutskommuniké 2011 |
2011-11-24 | Kvartalsrapport 2011-Q3 |
2011-05-26 | X-dag ordinarie utdelning RAY B 0.50 SEK |
2011-05-25 | Årsstämma |
2011-05-04 | Kvartalsrapport 2011-Q1 |
2011-02-18 | Bokslutskommuniké 2010 |
2010-11-12 | Kvartalsrapport 2010-Q3 |
2010-08-27 | Kvartalsrapport 2010-Q2 |
2010-05-26 | X-dag ordinarie utdelning RAY B 0.50 SEK |
2010-05-25 | Årsstämma |
2010-05-11 | Kvartalsrapport 2010-Q1 |
2009-11-20 | Kvartalsrapport 2009-Q3 |
2009-08-27 | Kvartalsrapport 2009-Q2 |
2009-05-27 | X-dag ordinarie utdelning RAY B 0.00 SEK |
2009-05-26 | Årsstämma |
2009-05-15 | Kvartalsrapport 2009-Q1 |
2008-06-25 | Split RAY B 1:3 |
2003-06-10 | Split RAY B 20:1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
RaySearch Laboratories AB (publ) announces that Mevion China has placed an order for RayStation®* which Mevion China has sold together with Mevion's HYPERSCAN® proton therapy system to Tongji Hospital in Wuhan in China.
RaySearch and Mevion have been collaborating since 2014. Treatment planning for particle treatments (protons/carbon ions/BNCT) is an important focus area for RaySearch and today RayStation has a global market share of more than 50 percent, a position that is further strengthened by the new order.
RaySearch has about 70 RayStation customers in China through its own subsidiary in the country.
Xianglin Yuan, Executive Director of the Radiotherapy Department of Wuhan Tongji Hospital, says: "Our Optics Valley Campus Proton Therapy Center has been equipped with Mevion S250 proton therapy system and RaySearch's treatment planning system RayStation to jointly build a world-leading proton therapy research center and a base for cooperation between medical science and the industry, creating a new level for proton therapy."
Johan Löf, founder and CEO, RaySearch, says: "I am happy that we have signed our first agreement with Mevion China and look forward to our collaboration and to be able to contribute to further improving the treatment for cancer patients at Tongji Hospital."
The order value is approximately MSEK 10, excluding service contract.
About Tongji Hospital
Tongji Hospital, Tongji Medical College and Huazhong University of Science & Technology are located in Wuhan in the Hubei Province of China. Tongji Hospital was founded by the German doctor Erich Paulun in Shanghai in 1900. Today it is a prominent hospital integrating medical care, teaching, and research in all disciplines. Read more on tjh.com.cn.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available on raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also
seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory clearance in some markets.
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8 510 530 00, johan.lof@raysearchlabs.com
Björn Hårdemark, interim CFO, RaySearch Laboratories AB (publ)
Tel: +46 (0) )709 564 217, bjorn.hardemark@raysearchlabs.com